Cas 874632-84-5,4,5,6-trimethyl-2-(3-phenyl-[1,2,4]oxadiazol-5-yl)-thieno[2,3-b]pyridin-3-ylamine

874632-84-5

Post Buying Request

Basic information

Product Name: 4,5,6-trimethyl-2-(3-phenyl-[1,2,4]oxadiazol-5-yl)-thieno[2,3-b]pyridin-3-ylamine
Synonyms: 4,5,6-trimethyl-2-(3-phenyl-[1,2,4]oxadiazol-5-yl)-thieno[2,3-b]pyridin-3-ylamine
CAS NO:874632-84-5
Molecular Formula:
Molecular Weight: 336.417
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4,5,6-trimethyl-2-(3-phenyl-[1,2,4]oxadiazol-5-yl)-thieno[2,3-b]pyridin-3-ylamine(CAS DataBase Reference)
NIST Chemistry Reference: 4,5,6-trimethyl-2-(3-phenyl-[1,2,4]oxadiazol-5-yl)-thieno[2,3-b]pyridin-3-ylamine(874632-84-5)
EPA Substance Registry System: 4,5,6-trimethyl-2-(3-phenyl-[1,2,4]oxadiazol-5-yl)-thieno[2,3-b]pyridin-3-ylamine(874632-84-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 874632-84-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

874632-84-5 Suppliers

Recommended suppliers

874632-84-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 874632-84-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,6,3 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 874632-84:
(8*8)+(7*7)+(6*4)+(5*6)+(4*3)+(3*2)+(2*8)+(1*4)=205
205 % 10 = 5
So 874632-84-5 is a valid CAS Registry Number.

874632-84-5Upstream product

874632-84-5Downstream Products

874632-84-5Relevant academic research and scientific papers

Methods for treating Hepatitis C

-

Page/Page column 121; 122, (2010/02/15)

In accordance with the present invention, compounds that can inhibit viral replication, preferably Hepatitis C Virus (HCV) replication, have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the treatment or prevention of a viral infection are provided. In another aspect of the invention, compounds useful in the treatment or prevention of HCV infection are provided.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 874632-84-5